Bhumi Pharmaceuticals
Indian Pharmaceutical Exporter · Antibiotics Specialist · $1.5M Total Trade · DGFT Verified
Bhumi Pharmaceuticals is an Indian pharmaceutical exporter with a total trade value of $1.5M across 2 products in 2 therapeutic categories. Based on 50 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ampicillin ($1.3M), Mebendazole ($158.3K), .
Bhumi Pharmaceuticals — Export Portfolio & Destination Treemap

Who is Bhumi Pharmaceuticals? — Company Overview & Market Position
Established in 2013, Bhumi Pharmaceuticals is a prominent manufacturer and exporter of pharmaceutical products based in Vadodara, Gujarat, India. The company specializes in a diverse range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Operating under the leadership of CEO Prakash Kachhwani, Bhumi Pharmaceuticals has grown to employ approximately 100 professionals. The company is registered under the Corporate Identification Number (CIN) U51909GJ2021PTC128070 and maintains an authorized capital of ₹0.10 million with a paid-up capital of ₹0.10 million. Bhumi Pharmaceuticals' annual turnover is reported to be between ₹25 to ₹100 crore, reflecting its significant presence in the pharmaceutical industry. The company's official website is www.bhumipharma.com, providing comprehensive information about its products and services.